December 14, 2022 Diagnosing and Treating Radiation Necrosis / Adverse Radiation Effect Samuel Chao, MD
November 9, 2022 The Current State of the Medical Literature and Getting Published Douglas Kondziolka, MD, MSc, FRCSC, FACS
July 21, 2022 International Practice Patterns and Clinical Target Volume Recommendations for SBRT for Non-spine Bone Metastases Chia-Lin (Eric) Tseng, MD, FRCPC Timothy Nguyen, MD
June 7, 2022 Analyzing the Evidence for Stereotactic Radiosurgery for Non-functioning Pituitary Adenomas Rupesh Kotecha, MD
May 6, 2022 Stereotactic Radiosurgery for Post-operative Metastatic Surgical Cavities Kristin Redmond, MD, MPH
April 27, 2022 Stereotactic Radiosurgery in the Management of Limited (1-4) Brain Metastases Samuel Chao, MD
April 8, 2022 PseudoPatient Technology – A Personalized Pretreatment Verification in SRS – Part 2 Georgios Kritselis, MD
March 25, 2022 Stereotactic Radiosurgery for the Management of Hypersecretory Syndromes Associated with Pituitary Adenomas David Mathieu, MD
March 4, 2022 Stereotactic Radiosurgery for Tremor: Systematic Review Cristina Torres, MD, PhD Nuria Martinez Moreno, MD, PhD
February 24, 2022 Evidence, Guidelines, Anecdote: State of the Data on Stereotactic Radiosurgery for Low-Grade Arteriovenous Malformations Christopher Graffeo, MD, MS
January 24, 2022 Radiosurgery For Intracranial Noncavernous Sinus Benign Meningioma Marcello Marchetti, MD, PhD
December 9, 2021 Stereotactic Ablative Radiotherapy for Prostate Cancer – the Past, Present, and Future Danny Vesprini, MD MSc FRCPC
October 14, 2021 A Comprehensive Review of The Role of Radiotherapy for Bone Metastases: When Do we use advanced techniques in era of new systemic agents? Quynh-Nhu Nguyen, M.D., M.H.C.M.
September 28, 2021 PseudoPatient Technology – A Personalized Pretreatment Verification in SRS Georgios Kritselis, MD
July 26, 2021 Expanding the Utility of SBRT in Hepatobiliary and Pancreas Malignancies Yoo Young (Dominique) Lee, MBChB, FRANZCR
July 6, 2021 Advances and Updates in Stereotactic Ablative Radiotherapy in the Treatment of Breast Cancer Elysia Donovan, MD, MSc, FRCPC
